The role
The Medical Science Liaison Manager (MSL) will play a pivotal role in preparing the market for the launch of a rare disease asset within the CNS space and act as the scientific face of the organisation across the lifecycle of the brand.
The MSL will establish and nurture long-term relationships with healthcare professionals within the target therapeutic area. While these professionals will primarily operate within a designated geographic territory, occasional cross-border engagement to engage other healthcare professionals may be required.
The MSL will seek to identify unmet medical needs and establish dissatisfaction with the current treatment paradigm, establishing a strong scientific foundation for future commercial success. Key responsibilities will include gathering and translating complex scientific, market, and competitor insights into actionable messages, which will help shape both medical and commercial strategies.
The client may also seek clinical support, including, but not restricted to, named patient programmes, accelerating patient recruitment for clinical trials, clinical protocol development, regulatory strategy and target product profile development.
The MSL will be an important member of a specialist launch team tasked with successfully launching the asset into Europe for our client.
ESSENTIAL DUTIES AND RESPONSIBILITIES:
Responsibilities
KOL & Stakeholder Engagement:
- Serve as the scientific representative for the organization throughout the brand lifecycle.
- Build and sustain mutually beneficial relationships with healthcare professionals who can be mobilized in support of the brand.
- Develop and maintain an up-to-date stakeholder map, identifying and engaging current and future emerging scientific leaders in rare disease.
- Support KOLs create access to medicine for their patients through named patient programmes
Market Insights:
- Generate actionable insights from multiple channels, including digital and in-person, face to face engagements, meetings, conferences, publications, and academic sources.
- Support Health Economics and Outcomes Research (HEOR) teams to build their value proposition by providing insights into unmet needs, disease burden, and real-world evidence (RWD).
Scientific Communication:
- Stay informed on emerging treatments, novel mechanisms of action, and competitor developments to continually update scientific and therapeutic knowledge.
- Establish credentials as an expert in the field to both internal and external stakeholders
- Support the development of high-quality, non-promotional scientific presentations which establish unmet needs and create dissatisfaction with existing treatment choices
- Facilitate medical information enquiry responses
- Support internal training for sales teams, commercial partners, and new MSLs, ensuring scientific consistency.
- Support the development of medical education materials in compliance with regulations.
Patient Advocacy & External Collaborations:
- Build strong relationships with patient organizations and advocacy groups, aligning with their needs and the rare disease community.
- Support disease awareness campaigns and early diagnosis initiatives in partnership with medical societies and healthcare networks.
Investigator & Clinical Research Support:
- Act as a key contact for investigators developing Investigator-Initiated Research (IIR).
- Provide scientific training and support to investigators and site staff as needed.
- Support patient recruitment accelerator programmes
- Author publications, white papers and training documents as appropriate
Congress & Scientific Event Leadership:
- In collaboration with medical communications, agree on conference strategy and core objectives for the investment in each meeting.
- Ensure outcomes against pre defined objectives and key learnings are shared in a timely fashion following the meeting.
- Organise 911 meetings as appropriate when red flags emerge.
Medical Affairs & Cross-functional Collaboration:
- Contribute expert input to the Product Medical Affairs Team, supporting the medical plan, lifecycle management strategies, and disease awareness initiatives.
- Participate in planning and executing scientific advisory boards (AdBoards) to gather expert insights.
- Work closely with Regulatory Affairs, Market Access, and Commercial teams to provide scientific support, ensuring compliance with non-promotional standards.
Compliance & Ethical Standards:
- Act as the champion for compliant activities
- Comply with all internal, regional and local laws and regulations as defined by the competent authorities
- Maintain upto date knowledge on any changes and share with internal organization where appropriate
- Ensure company is compliant with pharmacovigilance and adverse even reporting
- Ensure full adherence to EU, local (AIFA, MHRA, EMA), and international regulations governing MSL activities and HCP engagement.
- Maintain up-to-date knowledge of EFPIA, ABPI (UK), AIFA (Italy), and other relevant codes of conduct.
- Document and report interactions and insights in compliance with pharmacovigilance (PV), adverse event (AE) reporting, and company SOPs.
Data Generation ,Real-World Evidence (RWE) and Early Access Programms:
- Contribute to data generation initiatives, including post-marketing studies, patient registries, and RWE projects.
- Collaborate with cross-functional teams to identify evidence gaps and support the creation of publications, abstracts, and white papers.
- Reactive scientific support for company sponsored early access programmes.
Technology & Digital Engagement:
- Utilize digital tools and social media strategies to engage with Digital Opinion Leaders (DOLs) and extend KOL outreach. (A digital ninja)
- Use CRM tools and data analytics to track HCP engagement and measure field impact.
- Contribute to the development and optimization of scientific digital platforms, webinars, and virtual congresses.
- Utilise AI where efficiencies can be found and accuracy is assured.